Sinovac Biotech Ltd.
Sinovac Biotech Ltd., a prominent player in the biopharmaceutical industry, is headquartered in Beijing, China. Founded in 2001, the company has established itself as a leader in the development, manufacture, and commercialisation of vaccines, particularly in the fields of infectious diseases. Sinovac's core products include its inactivated vaccines for hepatitis A, hepatitis B, and influenza, which are distinguished by their rigorous safety and efficacy standards. With a strong presence in Asia and expanding operations globally, Sinovac has achieved significant milestones, including the development of its COVID-19 vaccine, CoronaVac, which has been pivotal in various vaccination campaigns worldwide. The company’s commitment to innovation and public health has solidified its market position, making it a trusted name in vaccine production and distribution.
DitchCarbon Score
How does Sinovac Biotech Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sinovac Biotech Ltd.'s score of 20 is lower than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Sinovac Biotech Ltd.'s reported carbon emissions
Sinovac Biotech Ltd., headquartered in China (CN), currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company has not established any formal reduction targets or commitments under the Science Based Targets initiative (SBTi) or other recognised frameworks. While there are commitments from related entities, such as Sinova GmbH, these do not directly reflect Sinovac Biotech Ltd.'s climate strategy. Sinova GmbH has a near-term target status classified as "Committed," but details on specific targets or achievements are not provided. In the context of the biopharmaceutical industry, companies are increasingly expected to disclose their carbon footprints and set ambitious reduction targets to align with global climate goals. Sinovac Biotech Ltd. may need to enhance its climate commitments to remain competitive and responsible in an evolving regulatory landscape.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sinovac Biotech Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
